Published in Oncology (Williston Park) on September 01, 1988
The clinical implications of medulloblastoma subgroups. Nat Rev Neurol (2012) 2.12
Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet (1992) 0.99
Deletion mapping on chromosome 17p in medulloblastoma. Br J Cancer (1997) 0.89
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08
Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg (1998) 2.75
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg (1998) 2.22
Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer (1995) 1.67
Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group. J Neurooncol (1998) 1.48
Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res (2001) 1.45
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol (2000) 1.44
Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer (1993) 1.40
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol (1998) 1.36
Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol (2006) 1.27
Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg (1996) 1.25
Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery (2000) 1.24
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. J Clin Oncol (1998) 1.24
Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.19
Fusarium brain abscess. Case report. J Neurosurg (1983) 1.17
Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas. AJNR Am J Neuroradiol (2010) 1.14
A case report and literature review of "primary" pulmonary histiocytosis X of childhood. Med Pediatr Oncol (1986) 1.14
Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer (1994) 1.11
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol (1996) 1.08
High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors. J Neurooncol (1999) 1.06
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol (1994) 1.06
Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol (1998) 1.04
Treatment of high-grade spinal cord astrocytoma of childhood with "8-in-1" chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group. J Neurosurg (1998) 1.02
Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study. Neuro Oncol (2001) 1.01
High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol (1998) 0.97
Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediatr Oncol (1996) 0.94
Renal cell carcinoma in childhood and adolescence: a retrospective survey for prognostic factors in 22 cases. J Pediatr Surg (1996) 0.93
Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer (1990) 0.93
Bone-marrow microenvironment defect in congenital hypoplastic anemia. N Engl J Med (1980) 0.92
Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial. J Clin Oncol (1995) 0.92
Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. Ann Neurol (1990) 0.92
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg (1996) 0.91
Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg (1997) 0.90
Acute lymphoblastic leukemia with Burkitt cell morphology and cytoplasmic immunoglobulin. Blood (1980) 0.89
Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurooncol (1992) 0.89
Successful treatment of metastatic retinoblastoma. Cancer (2000) 0.88
Nutritional vitamin B12 deficiency in a breastfed infant following maternal gastric bypass. Pediatr Hematol Oncol (1994) 0.87
Preliminary results of conformal radiation therapy for medulloblastoma. Neuro Oncol (1999) 0.86
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplant (2000) 0.86
Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group. Med Pediatr Oncol (1999) 0.86
Central nervous system (CNS) tumors in the first six months of life: the Children's Hospital Los Angeles experience, 1979-2005. Pediatr Hematol Oncol (2010) 0.86
Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study. J Clin Oncol (2000) 0.85
Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol (2008) 0.85
Effects of recombinant human interferon gamma on hematopoietic progenitor cell growth. Exp Hematol (1986) 0.84
Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers. Drugs (1999) 0.83
Clear cell sarcoma and selective IgM deficiency: a case report. Cancer (1982) 0.82
Chemotherapy for high-grade gliomas of childhood. Childs Nerv Syst (1999) 0.82
High-dose chemotherapy in childhood brain tumors. Onkologie (2004) 0.81
Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Cancer Treat Rep (1985) 0.80
Infectious complications in pediatric patients undergoing transplantation with T lymphocyte-depleted bone marrow. Pediatr Infect Dis (1986) 0.80
Lymphocyte dysfunction in congenital hypoplastic anemia. J Clin Invest (1982) 0.80
Surgery in the management of primary intracranial germ cell tumors. Childs Nerv Syst (1999) 0.80
Congenital mesoblastic nephroma with metastasis to the brain: a case report. Am J Pediatr Hematol Oncol (1994) 0.79
Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Childs Nerv Syst (1998) 0.79
Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood? Pediatr Neurosurg (1996) 0.79
Recent advances in the diagnosis and treatment of central nervous system germ-cell tumours. Curr Opin Neurol (1999) 0.79
Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation. Cancer (1987) 0.79
Prophylactic acyclovir in patients receiving bone marrow transplants. N Engl J Med (1985) 0.79
High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery. Bone Marrow Transplant (1996) 0.78
Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol (1996) 0.78
Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens. Exp Hematol (1986) 0.78
Optic glioma associated with Beckwith-Wiedemann syndrome. Pediatr Neurol (1989) 0.77
High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma. J Neurooncol (1996) 0.77
Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas? Cancer (1991) 0.77
The Drash syndrome revisited: diagnosis and follow-up. Am J Med Genet Suppl (1987) 0.77
Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement. J Biol Response Mod (1984) 0.77
Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow. J Biol Response Mod (1985) 0.76
Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors. Pediatr Neurosurg (1997) 0.76
Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881. J Neurooncol (1999) 0.76
Preirradiation chemotherapy. Childs Nerv Syst (1994) 0.75
Patterns of antigen expression in hepatoblastoma and hepatocellular carcinoma in childhood. Pediatr Hematol Oncol (1989) 0.75
Oxidative metabolism of circulating neutrophils in infantile (Philadelphia chromosome-negative) chronic myelogenous leukemia. Pediatr Hematol Oncol (1986) 0.75
In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease. Cancer Res (1986) 0.75
Pediatric bone marrow transplantation: current progress and future prospects. Pediatrics (1983) 0.75
Liver transplantation for primary hepatic cancer in childhood. Lancet (1987) 0.75
Haploidentical bone marrow transplantation for osteopetrosis. Am J Pediatr Hematol Oncol (1987) 0.75
The expanding role of chemotherapy for pediatric supratentorial malignant gliomas. J Neurooncol (1996) 0.75
Immunologic mechanisms in aplastic anemia. Am J Pediatr Hematol Oncol (1980) 0.75
A dramatic loss of non-verbal intelligence following a right parietal ependymoma: brief case report. Psychooncology (2000) 0.75
"Outcome of post-radiation secondary glioblastoma in children". Med Pediatr Oncol (1998) 0.75